2026-08-05
On August 5, 2026, under continued media questioning, the pharmaceutical company involved confirmed that a boy in a gene-editing trial at Shanghai Children's Medical Center died in August 2025 from a serious adverse reaction, after the parties involved had concealed the information and not made it public.